Moving into 2022, the COVID pandemic unfortunately continues to dominate headlines. However, it’s not all bad news. AIS Health spoke with a variety of industry experts, including Precision’s Cynthia Miller and Reta Mourad, about the myriad ways COVID-19 will continue to impact pharma this year and beyond.
Two new pharmacy benefit managers (PBMs), the Cost Plus Drug Company and PBGH, are looking to promote drug pricing transparency, which larger PBMs have been reluctant to do. Precision’s Cynthia Miller and Reta Mourad discuss the companies’ markedly different business models to lower drug prices and the challenges that lie ahead.
To get healthcare costs under control and “bend the cost curve,” the Centers for Medicare & Medicaid Services is moving from a volume-based reimbursement model to one based on value. To that end, the Center for Medicare & Medicaid Innovation has developed over a dozen new voluntary and mandatory value-based payment models.
While misinformation has plagued the public health field for decades, social media has amplified its spread. Both medical and public health leaders are beginning to develop strategies for this public health crisis. Precision’s Cynthia Miller lists three ways pharma companies can work with stakeholders to address cancer misinformation using evidence-based approaches.
As the use of real-world data in the health care system grows, a recent HHS rule giving patients electronic access to their data stands to have a huge impact on this area. Precision’s Dominic Galante weighs in on the 21st Century Cures Act, including a discussion of stakeholders that could benefit from the rule and the potential for innovations within the health care system.
Over the last decade, value-based reimbursement models have garnered a mountain of interest, but challenges in building a data infrastructure that can identify outcome metrics and logistics to dispense payments have largely relegated these models to anecdotal status. Recent deals by Pfizer and Takeda may indicate a step forward. Precision’s Ryan Cox weighs in on the evolving state of value based reimbursement models.
Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision’s Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.
Listen as PRECISIONvalue’s Mike Chambers sits down with Ethan Beute, host of The Customer Experience Podcast, to discuss why relationship and responsiveness are at the center of customer experience, as well as other key insights regarding sales strategies.
Are you attending LTEN 2021, November 8-11? Don’t miss the workshop “Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D” on Wednesday, 11/10 at 3:30pm MST | 5:30pm EDT in the Cottonwood 6 room!
Anshul Mangal (President of Project Farma and Precision ADVANCE) and Phil Cyr (SVP, Customer Solutions at Precision Value & Health) sat down with Samantha Black (Editor in Chief at ScienceBoard) to discuss how Precision ADVANCE is driving innovation in the advanced therapy sector by improving patient access through interconnected services across the drug development spectrum.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
